Agenus to Report Second Quarter 2013 Financial Results on July 25, 2013; Conference Call to Follow

Agenus to Report Second Quarter 2013 Financial Results on July 25, 2013;
Conference Call to Follow

LEXINGTON, Mass., July 18, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN)
will release its second quarter 2013 financial results before the market opens
on July 25, 2013.

Agenus executives will host a conference call at 11:00 a.m. Eastern Time that
same day. To access the live call, dial 647-426-1845.The call will also be
webcast and will be accessible from the company's website at
www.agenusbio.com/webcast/.A replay will be available approximately two hours
after the call through midnight Eastern Time on August 25, 2013.The replay
number is 416-915-1035, and the access code is 102913. The replay will also be
available on the company's website approximately two hours after the live
call.

Agenus Inc. is a biotechnology company working to develop treatments for
cancers and infectious diseases. The company is focused on immunotherapeutic
products based on strong platform technologies with multiple product
candidates advancing through the clinic, including several product candidates
that have advanced into late-stage clinical trials through corporate partners.
Between Agenus and its partners, 21 programs are in clinical development. For
more information, please visit www.agenusbio.com.

CONTACT: Media and Investor Contact:
         Jonae R. Barnes
         Vice President
         Investor Relations and
         Corporate Communications
         jonae.barnes@agenusbio.com
         617-818-2985

company logo
 
Press spacebar to pause and continue. Press esc to stop.